This conference will be an opportunity to explore the future of genomic transformation in the NHS, looking at screening and personalised medicine, workforce education and training, and the options for pharmacogenomics in clinical practice.
Following the shared commitments across the UK nations for implementing Genome UK 2022 to 2025, delegates will also discuss opportunities for UK-wide collaboration in research and development of novel treatments.
Key areas for discussion include:
- opportunities – latest thinking on the use and potential of genomics to improve public health and develop personalised medicine – next steps for data use – genomics in screening
- R&D – priorities for supporting innovation and collaborating on evaluation at UK level – systems to support innovative therapies – integration of health and genomic data in research
- pathogen genomic sequencing – taking forward lessons from systems used during the pandemic – the next steps for embedding capacity and scalability within the system
- implementation – the way forward for genomic transformation in the NHS
- pharmacogenomics – its role in drug discovery and prescribing – what has been learned from early developments – patient engagement – options for scaling up use in clinical practice
- collaboration and investment across the UK – key considerations for sharing data and key findings, and for surveillance
- developing genomic healthcare services – improving pathways – priorities for workforce education – reducing regional variation in implementation – opportunities for patient engagemen
During the conference delegates will hear from Professor Dame Sue Hill, Chief Scientific Officer for England and Senior Responsible Officer for Genomics; NHS England and NHS Improvement; Dr Rob Orford, Chief Scientific Adviser for Health in Wales, Welsh Government; and Dr Richard Scott, Chief Medical Officer, Genomics England; Consultant, Great Ormond Street Hospital for Children; and Honorary Senior Lecturer, Institute of Child Health, University College London.
The conference will be an opportunity for stakeholders to consider the issues alongside key policy officials who are due to attend from the Department of Health, NI; Office for Life Sciences; The Scottish Government; and the Welsh Government. Book your place now.
